October is Breast Cancer Awareness month. In 2020, there were 2.3 million women diagnosed with breast cancer and 685 000 deaths globally. As of the end of 2020, there were 7.8 million women alive who were diagnosed with breast cancer in the past 5 years, making it the world’s most prevalent cancer.
This Cancer Lecture series explores BRCA genetic testing, overcoming the clinical challenges and the psychosocial impact of breast cancer.
“Cervical Cancer Elimination” | 15 September 2021
Dr Julie Torode | Prof Lynette Denny | Prof Greta Dreyer
In honor of gynaecological cancer awareness month, our September cancer lecture focused on cervical cancer elimination.
In May 2018, the WHO Director-General announced a global call for action to eliminate cervical cancer, underscoring renewed political will to make elimination a reality and calling for all stakeholders to unite behind this common goal. In August 2020 the World Health Assembly adopted the Global Strategy for cervical cancer elimination.
Almost a year later, our panel spoke on the steps and challenges towards eliminating cervical cancer as a public health problem.
“Global Oncology” | 24 August 2021
Dr Satish Gopal
Dr Satish Gopal (M.D., M.P.H.) is the Director of the Center for Global Health at the National Cancer Institute (NCI). His role includes overseeing the development initiatives and collaborations with other NCI divisions, NCI-Designated Cancer Centers, and countries to support cancer-research and-networks, promote cancer control planning, and build capacity in developing countries. Dr Gopal completed his Master of Public Health at UNC-Chapel Hill (2000), a medical degree from Duke University School of Medicine (2001), completed his internal medicine and paediatrics training (University of Michigan) and training in medical oncology and infectious diseases (UNC-Chapel Hill). As an extramural investigator, his NIH-funded research program focuses on epidemiologic, clinical, and translational studies of lymphoma and HIV-associated malignancies in sub-Saharan Africa, and he has previously overseen a broad, multidisciplinary cancer research portfolio addressing many of the commonest cancers in the region, including cervical, breast, and oesophageal cancer.